Catherine McGuinn

7PUBLICATIONS
19CO-AUTHORS
HaematologyPharmaceutical delivery technologiesRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 02, 2022
A review of the pharmacokinetics, efficacy and safety of high-purity factor X for the prophylactic treatment of hereditary factor X deficiency.

Jeanette Payne, Glaivy Batsuli, Andrew D Leavitt

|Mar 09, 2022
Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain.

Erik Berntorp, Petra LeBeau, Margaret V Ragni

|Dec 19, 2021
A roadmap for better management for synovitis in haemophilia.

Catherine McGuinn

|Jul 29, 2021
Haemophilia: factoring in new therapies.

Hannah Fassel, Catherine McGuinn

|Dec 05, 2020
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural).

Amy D Shapiro, Margaret V Ragni, Munira Borhany

|Jun 30, 2020
Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A.

Pratima Chowdary, Eric S Mullins, Barbara A Konkle

Pageof 2